Intestinal Gluconeogenesis: Emerging Regulator of Energy Homeostasis
Obesity and type 2 diabetes continuously progress worldwide, compromising healthy aging. Deregulated endogenous glucose production (EGP) is involved in hyperglycemia and its complications. Among the 3 organs (liver, kidney, intest...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PID2020-117640RB-I00
COMPLICACIONES EMERGENTES DEL DESAJUSTE DE LA HOMEOSTASIS GL...
194K€
Cerrado
TRUSTED
CenTral and PeRipheral NervoUs SyStem acTion of GIPR in ObEs...
2M€
Cerrado
SAF2015-65019-R
MECANISMOS FISIOPATOLOGICOS DEL EJE SUCCINATO/SUCNR1 EN LA O...
169K€
Cerrado
BFU2011-25420
MECANISMOS MOLECULARES Y CELULARES IMPLICADOS EN LA PATOGENE...
97K€
Cerrado
AstroNeuroCrosstalk
Astrocyte Neuronal Crosstalk in Obesity and Diabetes
1M€
Cerrado
BFU2015-70664-R
PAPEL DE P53 Y P63 HEPATICOS EN LA HOMEOSTASIS METABOLICA. I...
242K€
Cerrado
Información proyecto IGN
Duración del proyecto: 63 meses
Fecha Inicio: 2023-06-20
Fecha Fin: 2028-09-30
Descripción del proyecto
Obesity and type 2 diabetes continuously progress worldwide, compromising healthy aging. Deregulated endogenous glucose production (EGP) is involved in hyperglycemia and its complications. Among the 3 organs (liver, kidney, intestine) contributing to EGP, I uncovered with my team that intestinal gluconeogenesis (IGN) has the capacity to interfere in the control of energy homeostasis. Indeed, intestinal glucose initiates a gut-brain circuit controlling both body weight and glucose production by the liver, the strongest quantitative contributor to EGP. Intestinal gluconeogenesis is, thus, a novel target to control obesity and diabetes.
The IGN project has 3 objectives:
Understand: is dedicated to elucidating the neural mechanisms by which IGN is sensed and send its signals to the brain. Our data suggested that glucose receptor sodium-glucose co-transporter 3 (SGLT3) could be the peripheral sensor of IGN. Moreover, we showed that the neuromediator calcitonin gene-related peptide alpha (CGRPa) is mandatory for the IGN signal. I will use original mouse models to map the SGLT3-neuron connection to the brain and define the role of CGRPa.
Explore: aims at expanding the scope of IGN to the networking of hypothalamus during the neonatal period. I will assess whether the surge of IGN occurring during the neonatal period may control the development of neuronal connections between the hypothalamic nuclei, to ensure an optimal control of energy homeostasis in adult, as previously observed for the neonatal surge of the hormone leptin.
Take advantage: aims at identifying novel metabolites able to activate IGN and test them as beneficial modulators of energy homeostasis under unbalanced nutrition. This will pave the way to novel therapeutic approaches of metabolic diseases based on IGN.
Thus, the IGN project should lead to a better understanding of metabolic control and offer new perspectives for preventing metabolic diseases and maintaining healthy ageing.